Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Invested Capital (2023 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Return on Invested Capital for 5 consecutive years, with 0.42% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 17.0% year-over-year to 0.42%, compared with a TTM value of 0.42% through Dec 2025, down 17.0%, and an annual FY2025 reading of 0.34%, changed 0.0% over the prior year.
  • Return on Invested Capital was 0.42% for Q4 2025 at Agios Pharmaceuticals, down from 0.25% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.25% in Q4 2024 and bottomed at 0.42% in Q4 2025.
  • Average Return on Invested Capital over 3 years is 0.35%, with a median of 0.37% recorded in 2023.
  • The sharpest move saw Return on Invested Capital increased 9bps in 2024, then dropped -17bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.42% in 2023, then soared by 39bps to 0.25% in 2024, then crashed by -67bps to 0.42% in 2025.
  • Business Quant data shows Return on Invested Capital for AGIO at 0.42% in Q4 2025, 0.25% in Q4 2024, and 0.33% in Q3 2024.